A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE Read more about A NOVEL ANTIPROLIFERATIVE FACTOR AND METHODS OF USE US Patent 9,085,604Filed on 2007-12-13
TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY Read more about TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY MexicoMX/A/2008/005674Filed on 2006-11-08
TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY Read more about TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY Japan2008-540197Filed on 2006-11-08
IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES Read more about IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES Australia2009200792Filed on 2009-02-27
Melanoma Associated Peptide Analogues And Vaccines Against Melanoma Read more about Melanoma Associated Peptide Analogues And Vaccines Against Melanoma Japan115844/2009Filed on 2009-05-12
Modified T Cell Receptors and Related Materials and Methods. Read more about Modified T Cell Receptors and Related Materials and Methods. US Patent 8,088,379Filed on 2009-04-29
Compositions And Methods For Chitosan Enhanced Immune Response Read more about Compositions And Methods For Chitosan Enhanced Immune Response US Application 12/442,483Filed on 2009-03-23
Compositions And Methods For Chitosan Enhanced Immune Response Read more about Compositions And Methods For Chitosan Enhanced Immune Response European Patent07838692.7Filed on 2007-09-21
OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS Read more about OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS US Patent 8,216,783Filed on 2009-04-14
SCGB3A2 As A Growth Factor and Anti-Apoptotic Agent Read more about SCGB3A2 As A Growth Factor and Anti-Apoptotic Agent US Patent 8,133,859Filed on 2009-03-25